1. Home
  2. UMH vs PVLA Comparison

UMH vs PVLA Comparison

Compare UMH & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UMH

UMH Properties Inc.

HOLD

Current Price

$14.31

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$112.54

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMH
PVLA
Founded
1968
2015
Country
United States
United States
Employees
N/A
14
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UMH
PVLA
Price
$14.31
$112.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
16
Target Price
$17.75
$162.06
AVG Volume (30 Days)
496.5K
279.8K
Earning Date
04-30-2026
05-14-2026
Dividend Yield
6.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.62
N/A
Revenue Next Year
$2.51
N/A
P/E Ratio
$203.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.93
$18.23
52 Week High
$19.02
$151.18

Technical Indicators

Market Signals
Indicator
UMH
PVLA
Relative Strength Index (RSI) 33.78 46.19
Support Level $13.98 $109.36
Resistance Level $14.95 $147.47
Average True Range (ATR) 0.26 7.76
MACD -0.00 -2.84
Stochastic Oscillator 32.58 8.85

Price Performance

Historical Comparison
UMH
PVLA

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: